Q4 2019 CytomX Therapeutics Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the CytomX Therapeutics Fourth Quarter 2019 and Full-Year Financials Conference Call. (Operator Instructions) As a reminder, this call maybe be recorded. I would now like to introduce your host for today's conference, Christopher Keenan, Vice President of Investor Relations. Chris, you may begin.
Thank you, Leigh. Good afternoon, and thank you for joining us. Earlier today, we issued a press release that includes a summary of our recent progress and fourth quarter 2019 and full year financial results. This press release and a recording of this call can be found under the Investors and News section of our website at cytomx.com.
With me today are CytomX' President, Chief Executive Officer and Chairman; Dr. Sean McCarthy, CytomX' Chief Development Officer, Dr. Amy Peterson; and CytomX' Vice President of Finance, Robin Knifsend.
During today's call, we will be making forward-looking statements. Because forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |